Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10525046 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2020-01-07 |
| 10028944 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2018-07-24 |
| 9765053 | Methods of treatment using selective 5-HT2A inverse agonists | Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen | 2017-09-19 |
| 9566271 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2017-02-14 |
| 9296694 | Azacyclic compounds | Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen | 2016-03-29 |
| 9211289 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2015-12-15 |
| 8921393 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2014-12-30 |
| 8377959 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2013-02-19 |
| 8227487 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2012-07-24 |
| 8008323 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2011-08-30 |
| 7994193 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2011-08-09 |
| 7732462 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2010-06-08 |
| 7713995 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Norman Nash, Carl-Magnus A. Andersson | 2010-05-11 |
| 7659285 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2010-02-09 |
| 7601740 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson | 2009-10-13 |
| 7238713 | Muscarinic agonists | Carl-Magnus A. Anderson, Bo Lennart Mikael Friberg, Niels Skjaerbaek, Tracy Spalding | 2007-07-03 |
| 6815458 | Azacyclic compounds | Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen | 2004-11-09 |
| 6756393 | Azacyclic compounds | Carl-Magnus A. Andersson, Glenn Croston, Eva Louise Hansen | 2004-06-29 |
| 6627645 | Muscarinic agonists | Carl-Magnus A. Andersson, Bo Lennart Mikael Friberg, Niels Skjaerbaek, Tracy Spalding | 2003-09-30 |